Yaman02 Posted July 1, 2020 Report Posted July 1, 2020 HEALTH AND SCIENCE Pfizer stock jumps after it reports positive data in early-stage coronavirus vaccine trial  Pfizer shares jumped after it released positive results from its closely watched early-stage human trial on a coronavirus vaccine. The trial evaluated 45 people. Each participant received 10, 30 or 100 microgram doses of the vaccine or a placebo. Pfizer said the vaccine was generally well-tolerated, though the experimental vaccine also caused fever in some patients, especially for those who were in the 100 microgram group. Quote
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.